Victoza® (liraglutide) Received EU Marketing Authorization

Filed in archive Research , Treatment by Gloria Gamat on July 6, 2009

Novo Nordisk's prime diabetes drug called Victoza® (liraglutide) has now received narketing authorization by the EU.

Victoza is the first once-daily human glucagon-like peptide-1 (GLP-1) analog developed for the treatment of type 2 diabetes and is now authorized in all 27 European Union member states for:

combination treatment with metformin or a sulphonylurea in patients with insufficient glycemic control despite maximal tolerated dose of monotherapy with metformin or sulphonylurea, and

combination treatment with metformin and a sulphonylurea or metformin and a thiazolidinedione in patients with insufficient glycemic control despite dual therapy.

Taken once daily,Victoza® is first human Glucagon-Like Peptide-1 (GLP-1) analogue. Find out more at Novo Nordisk.

Related Entries:

Novo Nordisk Discontinues R&D on Small Molecules for Ora... - 23 January 2007
Liraglutide: Novo Nordisk Diabetes Drug, Better Than Insulin... - 21 June 2007
Anti-Diabetes Drug Candidate Liraglutide Improves Glucose Co... - 21 August 2007
Sciele Pharma Expands Diabetes Drug Portfolio With Novo Nord... - 20 November 2007

« Melon Extract Against Obe... | Main | Diabetes Awareness With J... »

Permalink: Victoza® (liraglutide) Received EU Marketing Authorization

Tags: diabetes diabetes Victoza liraglutide novo nordisk more liraglutide+received

Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/155978

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Vote for Victoza® (liraglutide) Received EU Marketing Authorization:

Currently 10.00/10
1
2
3
4
5
6
7
8
9
10

Rating: 10.00 out of 4 vote(s) cast.

Response from: keith (11/30/09 10:33am)

i have been using victoza for one week and my glucose level have come right down and no side effect

Add your response to Victoza® (liraglutide) Received EU Marketing Authorization:

Name: *

Email: (will never be shown)*

URL:

(* marked fields are required)

Notify me if more comments appear?

Subscribe to Daily Diabetic newsletter? (Newsletters are sent out weekly).

Remember me

Security Code: *
(Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)

We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Share It

Use the search to look for other interesting posts

Contributors (Last 90 days)

Creative Weblogging (9)

This site has 962 entries and is powered by Creative Weblogging since January 2006.

Our Editors recommend

Disclaimer

Some of the contents of this site are protected Creative Weblogging Inc. 2004-2010.

Check out our Sponsored Blogs!

Business Computer Blog (UK)

Testimonials

'Daily Diabetic is already one of my favorite resources for diabetes news. I enjoy the positive approach it takes, and recommend it to anyone with diabetes, or to anyone who wants to help people with diabetes.' -Jessica Thomas, Type 1 Diabetic

'Thank you for helping me stay in touch with the latest research.'-Scott Phillips

'This is just the worst for children. I dear friend of mine has a grand daughter who was recently diagnosed with Type I diabetes so we're reading up and gathering information and help and prefer it from REAL people. I thank you for sharing all the great information here as it's been a great help.' -JR